✦ LIBER ✦

CS14.3 The potential of genetically modified T cells to prevent HBV related HCC

✍ Scribed by A.J. Gehring

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delivery of neuroactive compounds to the

✍ Tuszynski, Mark H.; Jinnah, Hyder A.; Gage, Fred H. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Therapeutic potential of acyclovir and o

✍ Ouzan, D.; Fontanges, T.; Chevallier, M.; Chossegros, P.; Degos, F.; Chevallier, 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Avoiding the Need for Clinical-Grade OKT

✍ S.O. Ang; S.N. Maiti; C. Hartline; S. Olivares; H. Huls; R. Champlin; L.J.N. Coo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Age-related change in the potential of b

✍ Katsuiku Hirokawa; Sachiho Kubo; Masanori Utsuyama; Chieri Kurashima; Toshihiko 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 636 KB

870 EPIGENETIC REGULATION OF CELLULAR TA

✍ F. Guerrieri; L. Belloni; V. Schinzari; C.S. Scisciani; T. Pollicino; G. Raimond 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparative analysis of phase I and II e

✍ Jie Lin; Lilianna Schyschka; Ruben Mühl-Benninghaus; Jan Neumann; Liping Hao; Na 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 602 KB